Renaissance Technologies LLC Cuts Stock Position in Transcat, Inc. $TRNS

Key Points

• Renaissance Technologies cut its Transcat stake by 63.6% in the first quarter, selling 60,500 shares and retaining 34,700 shares worth about $2.55 million. Institutional investors collectively own 98.34% of the company.
• Transcat reported a quarterly earnings and revenue beat, posting $0.51 EPS versus the $0.38 consensus and $92.95 million in revenue versus $86.55 million expected.
• Analyst sentiment remains cautious: Transcat carries an average “Hold” rating with a $105.50 price target, while Northland downgraded the stock and reduced several future EPS forecasts. The shares also trade at an elevated trailing P/E above 250.

Renaissance Technologies LLC trimmed its stake in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 63.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,700 shares of the scientific and technical instruments company's stock after selling 60,500 shares during the period. Renaissance Technologies LLC owned 0.37% of Transcat worth $2,549,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. Lazard Asset Management LLC purchased a new stake in shares of Transcat during the second quarter worth about $54,000. Tower Research Capital LLC TRC lifted its stake in Transcat by 245.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company's stock valued at $97,000 after buying an additional 798 shares in the last quarter. Marshall Wace LLP acquired a new stake in Transcat in the 4th quarter worth about $236,000. Balyasny Asset Management L.P. acquired a new stake in Transcat in the 4th quarter worth about $247,000. Finally, Price T Rowe Associates Inc. MD increased its stake in Transcat by 8.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,265 shares of the scientific and technical instruments company's stock worth $299,000 after buying an additional 432 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Wall Street Zen raised Transcat from a "sell" rating to a "hold" rating in a report on Sunday, June 28th. Zacks Research raised Transcat from a "strong sell" rating to a "hold" rating in a research note on Friday, May 15th. Northland Securities cut Transcat from an "outperform" rating to a "market perform" rating and set a $95.00 price target for the company. in a research report on Wednesday, August 5th. Finally, Weiss Ratings raised Transcat from a "sell (d)" rating to a "sell (d+)" rating in a research note on Thursday, May 28th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, Transcat presently has an average rating of "Hold" and an average price target of $105.50.

Key Stories Impacting Transcat

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Transcat’s latest quarterly results exceeded expectations, with earnings of $0.51 per share versus the $0.38 consensus estimate and revenue of $92.95 million compared with expectations of $86.55 million. This indicates solid operating momentum, although the results are not the primary focus of today’s trading. TRNS Q2 deep dive: Service segment drives growth, margin pressures persist
• Neutral Sentiment: Northland’s $95 price target and “Market Perform” rating indicate a neutral stance rather than a bullish or bearish recommendation. Transcat Rating Lowered to Market Perform at Northland Securities
• Negative Sentiment: Northland cut its Q3 2027 EPS forecast to $0.20 from $0.38 and lowered FY2027 EPS to $1.71 from $1.86. It also reduced estimates for FY2028 to $2.12 from $2.33, FY2029 to $2.58 from $3.18, and FY2030 to $3.01 from $3.51.
• Negative Sentiment: The firm additionally lowered Q2 2027 EPS to $0.41 from $0.45, Q4 2027 EPS to $0.60 from $0.62, and FY2031 EPS to $3.53 from $3.88. The broad-based reductions imply weaker-than-previously-expected earnings growth and are likely weighing on the stock.
• Negative Sentiment: Transcat trades at a very elevated valuation, with a trailing P/E above 250. Downward revisions therefore create greater downside sensitivity, particularly while the stock is near its 52-week high.

Transcat Price Performance

TRNS stock opened at $93.11 on Monday. The company has a market cap of $871.51 million, a price-to-earnings ratio of 251.65 and a beta of 0.68. The company has a current ratio of 2.49, a quick ratio of 2.11 and a debt-to-equity ratio of 0.36. Transcat, Inc. has a 12 month low of $50.23 and a 12 month high of $96.60. The firm has a 50-day moving average of $89.60 and a two-hundred day moving average of $79.73.

Transcat (NASDAQ:TRNS - Get Free Report) last issued its earnings results on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. The business had revenue of $92.95 million for the quarter, compared to analysts' expectations of $86.55 million. Transcat had a return on equity of 5.56% and a net margin of 0.99%. As a group, analysts forecast that Transcat, Inc. will post 1.74 earnings per share for the current fiscal year.

About Transcat

Transcat, Inc NASDAQ: TRNS is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source